We Are Integrity Laboratories


Integrity Laboratories’ mission is to serve our clients by providing comprehensive, state-of-the-art esoteric laboratory testing on behalf of its client base and to do so with the highest standards of honesty, transparency, and integrity. This mission has shaped every decision we have made, from the creation of our impressive team to our dedication in making clinical laboratory testing accessible – with rapid precision – to our healthcare system relationships. We developed Integrity Laboratories to embrace a new era of innovation occurring in the biotechnology industry based on the following focuses:



Over the last 50 years, the biotechnology industry has gained traction throughout the world as the leader of new and exciting technology. And with this evolution, we have seen great strides in the accessibility of technology passed into the hands of many. In the health-tech sector, this impact has helped reshape and improve health and general wellbeing. In a time where the risk of illness is increasing, these advancements have played – and will continue to play – an essential role in combating disease.

At Integrity Laboratories, we have developed cutting-edge technology to improve clinical management of infectious disease. Committed to antimicrobial stewardship and targeted antimicrobial therapies, we deliver rapid and precise diagnostic data the first time, every time. Though we have directed the full breadth of our resources toward COVID-19 testing, we will continue to exceed expectations on behalf of our community and our healthcare partners for rapid diagnostic reporting.  But our brand doesn’t just represent our dedication to technology – we’re redefining the current paradigm to further enhance the relationship between the biotechnology industry and healthcare professionals.



Unfortunately, biotechnology has not always had a great reputation for making the jobs of healthcare professionals easier. Too often, advancements of technology in healthcare systems have led to greater challenges, such as increased costs for equipment and the time required for training. These are just a few of the unspoken hidden costs of biotechnology.


Reap the benefit of an expertly trained lab staff to precisely assess your samples and convert them into results.


Though technology may represent significant leaps and bounds in research, the ease of integration into a clinical setting has its own set of challenges. This model often forgets the dynamic necessity of an intermediary agent. Once biotechnology is honed and ready for industrial use, the burden of purchase and training falls onto the healthcare sector. Diverting funds to purchase equipment and train staff on an already exhausted system leaves many hospitals at risk of financial and environmental strain. At Integrity Laboratories, we identified this trend and sought to focus on easing the burden that healthcare institutions face incorporating innovative technology into their practices. By transitioning to a dual-purpose laboratory, we take on the burden of research and development to create the technology needed and offer the service of our lab to run the tests we develop. This results in the reduction of costs of equipment and improves the accessibility of a broad range of tests. This is design-thinking principles applied to healthcare.



With innovative science comes an obligation to do good. At Integrity Laboratories, we are defying the status quo in the biotech sphere. Our client-centered approach extends past the use of advanced research and technology and provides healthcare systems the relief they need. We provide ease of mind to our clients in knowing that each patient sample is run with an expert staff of precision-trained technicians for a highly accurate result – all in record time and delivered electronically through our automatic delivery system straight to your secure device. Discover actionable insights with a user-friendly design for all clinicians alike to provide your patients the care they need, when they need it, consistently.

Now that’s Integrity.

Integrity Laboratories began testing for SARS-CoV-2 (COVID-19) under Emergency Use Authorization (EUA) on March 23.

Please direct all inquiries to covid19@integritylaboratories.com for immediate review.

Click Here for CDC recommendations for Identifying Monkeypox.

FDA Authorization Letter   |   FDA EUA Summary

CARES Act Statement